{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:03:41Z","timestamp":1789603421660,"version":"build-2803163510"},"reference-count":342,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.apsb.2026.07.001","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T06:14:11Z","timestamp":1783318451000},"page":"5674-5708","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lipid nanoparticles as active biointerfaces: From membrane interaction to systemic dysregulation"],"prefix":"10.1016","volume":"16","author":[{"given":"Falko","family":"Seger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0020-0826","authenticated-orcid":false,"given":"L. Maria","family":"Gutschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8191-1049","authenticated-orcid":false,"given":"Stephanie","family":"Seneff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2026.07.001_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2021.101142","article-title":"Role of nanotechnology behind the success of mRNA vaccines for COVID-19","volume":"38","author":"Khurana","year":"2021","journal-title":"Nano Today"},{"key":"10.1016\/j.apsb.2026.07.001_bib2","article-title":"The role of lipid components in lipid nanoparticles for vaccines and gene therapy","volume":"188","author":"Hald","year":"2022","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.apsb.2026.07.001_bib3","doi-asserted-by":"crossref","first-page":"658","DOI":"10.3390\/vaccines11030658","article-title":"Recent advances in the lipid nanoparticle-mediated delivery of mRNA vaccines","volume":"11","author":"Swetha","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.apsb.2026.07.001_bib4","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.apsb.2026.07.001_bib5","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1021\/acs.molpharmaceut.2c00092","article-title":"Perspective on higher-order structure and thermal stability of mRNA vaccines","volume":"19","author":"Kloczewiak","year":"2022","journal-title":"Mol Pharm"},{"key":"10.1016\/j.apsb.2026.07.001_bib6","article-title":"Decoding pH-driven phase transition of lipid nanoparticles","volume":"14","author":"Trollmann","year":"2026","journal-title":"Small"},{"key":"10.1016\/j.apsb.2026.07.001_bib7","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1186\/s12951-024-02972-w","article-title":"Navigating the intricate in vivo journey of lipid nanoparticles tailored for the targeted delivery of RNA therapeutics: a quality-by-design approach","volume":"22","author":"Haghighi","year":"2024","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.apsb.2026.07.001_bib8","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1016\/j.bpj.2021.03.012","article-title":"Encapsulation state of messenger RNA inside lipid nanoparticles","volume":"120","author":"Brader","year":"2021","journal-title":"Biophys J"},{"key":"10.1016\/j.apsb.2026.07.001_bib9","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1021\/acs.accounts.1c00544","article-title":"Chemistry of lipid nanoparticles for RNA delivery","volume":"55","author":"Eygeris","year":"2022","journal-title":"Acc Chem Res"},{"key":"10.1016\/j.apsb.2026.07.001_bib10","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1089\/nat.2018.0721","article-title":"Lipid nanoparticles enabling gene therapies: from concepts to clinical utility","volume":"28","author":"Kulkarni","year":"2018","journal-title":"Nucleic Acid Therapeut"},{"key":"10.1016\/j.apsb.2026.07.001_bib11","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.jconrel.2024.07.046","article-title":"A perspective on bleb and empty LNP structures","volume":"373","author":"Simonsen","year":"2024","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2026.07.001_bib12","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1016\/j.bpj.2022.08.037","article-title":"mRNA lipid nanoparticle phase transition","volume":"121","author":"Trollmann","year":"2022","journal-title":"Biophys J"},{"key":"10.1016\/j.apsb.2026.07.001_bib13","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat Rev Mater"},{"key":"10.1016\/j.apsb.2026.07.001_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.cocis.2023.101705","article-title":"Review of structural design guiding the development of lipid nanoparticles for nucleic acid delivery","volume":"66","author":"C\u00e1rdenas","year":"2023","journal-title":"Curr Opin Colloid Interface Sci"},{"key":"10.1016\/j.apsb.2026.07.001_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2024.115291","article-title":"Lipid nanoparticles for RNA delivery: self-assembling vs driven-assembling strategies","volume":"208","author":"Nele","year":"2024","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.apsb.2026.07.001_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202302917","article-title":"Ionizable lipid with supramolecular chemistry features for RNA delivery in vivo","volume":"19","author":"Manning","year":"2023","journal-title":"Small"},{"key":"10.1016\/j.apsb.2026.07.001_bib17","doi-asserted-by":"crossref","first-page":"9983","DOI":"10.1080\/07391102.2024.2329307","article-title":"Mechanistic insights into interactions between ionizable lipid nanodroplets and biomembranes","volume":"43","author":"\u010cechov\u00e1","year":"2025","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.apsb.2026.07.001_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemphyslip.2023.105294","article-title":"Ionizable lipids penetrate phospholipid bilayers with high phase transition temperatures: perspectives from free energy calculations","volume":"253","author":"Ermilova","year":"2023","journal-title":"Chem Phys Lipids"},{"key":"10.1016\/j.apsb.2026.07.001_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2025.101585","article-title":"Design of cationic ionizable lipids for the delivery of therapeutic nucleic acids","volume":"33","author":"Atmuri","year":"2025","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.apsb.2026.07.001_bib20","doi-asserted-by":"crossref","first-page":"9909","DOI":"10.1021\/jp5028355","article-title":"Electroporation of asymmetric phospholipid membranes","volume":"118","author":"Gurtovenko","year":"2014","journal-title":"J Phys Chem B"},{"key":"10.1016\/j.apsb.2026.07.001_bib21","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/nature04398","article-title":"Plasma membrane phosphoinositide organization by protein electrostatics","volume":"438","author":"McLaughlin","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2026.07.001_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ceb.2024.102373","article-title":"Nonlinear dynamics in phosphoinositide metabolism","volume":"88","author":"Fung","year":"2024","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.apsb.2026.07.001_bib23","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1016\/j.bpj.2011.09.039","article-title":"Divalent cation-dependent formation of electrostatic PIP2 clusters in lipid monolayers","volume":"101","author":"Ellenbroek","year":"2011","journal-title":"Biophys J"},{"key":"10.1016\/j.apsb.2026.07.001_bib24","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2301985120","article-title":"The membrane electric field regulates the PIP2-binding site to gate the KCNQ1 channel","volume":"120","author":"Mandala","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2026.07.001_bib25","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.3390\/biology11121694","article-title":"PIP2 interacts electrostatically with MARCKS-like Protein-1 and ENaC in renal epithelial cells","volume":"11","author":"Yue","year":"2022","journal-title":"Biology"},{"key":"10.1016\/j.apsb.2026.07.001_bib26","article-title":"PI(4,5)P2 is a master regulator for Ca2+-triggered vesicle exocytosis","volume":"1870","author":"Yamaga","year":"2025","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"10.1016\/j.apsb.2026.07.001_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102035","article-title":"PKC regulation of ion channels: the involvement of PIP2","volume":"298","author":"Gada","year":"2022","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2026.07.001_bib28","first-page":"86","article-title":"Striking a balance: PIP2 and PIP3 signaling in neuronal health and disease","volume":"1","author":"Tariq","year":"2021","journal-title":"Explor Neuroprotective Ther"},{"key":"10.1016\/j.apsb.2026.07.001_bib29","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1007\/s12551-023-01166-2","article-title":"Electrostatic switch mechanisms of membrane protein trafficking and regulation","volume":"15","author":"Clarke","year":"2023","journal-title":"Biophys Rev"},{"key":"10.1016\/j.apsb.2026.07.001_bib30","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/eji.200737998","article-title":"DiC14-amidine cationic liposomes stimulate myeloid dendritic cells through toll-like receptor 4","volume":"38","author":"Tanaka","year":"2008","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.apsb.2026.07.001_bib31","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","article-title":"PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer","volume":"22","author":"Glaviano","year":"2023","journal-title":"Mol Cancer"},{"key":"10.1016\/j.apsb.2026.07.001_bib32","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1016\/j.molcel.2024.09.009","article-title":"Dual regulation of IP3 receptors by IP3 and PIP2 controls the transition from local to global Ca2+ signals","volume":"84","author":"Ivanova","year":"2024","journal-title":"Mol Cell"},{"key":"10.1016\/j.apsb.2026.07.001_bib33","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.advenzreg.2011.09.005","article-title":"Phospholipase C signaling and calcium influx","volume":"52","author":"Putney","year":"2012","journal-title":"Adv Bio Regul"},{"key":"10.1016\/j.apsb.2026.07.001_bib34","doi-asserted-by":"crossref","first-page":"7068","DOI":"10.1074\/jbc.RA118.004021","article-title":"K-Ras G-domain binding with signaling lipid phosphatidylinositol (4,5)-phosphate (PIP2): membrane association, protein orientation, and function","volume":"294","author":"Cao","year":"2019","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2026.07.001_bib35","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.bbrc.2018.07.155","article-title":"Regulation of actin assembly by PI(4,5)P2 and other inositol phospholipids: an update on possible mechanisms","volume":"506","author":"Janmey","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.apsb.2026.07.001_bib36","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11051-023-05690-w","article-title":"Structural parameters of nanoparticles affecting their toxicity for biomedical applications: a review","volume":"25","author":"Abbasi","year":"2023","journal-title":"J Nano Res"},{"key":"10.1016\/j.apsb.2026.07.001_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2024.172240","article-title":"Impact of physicochemical properties on biological effects of lipid nanoparticles: are they completely safe","volume":"927","author":"Yuan","year":"2024","journal-title":"Sci Total Environ"},{"key":"10.1016\/j.apsb.2026.07.001_bib38","doi-asserted-by":"crossref","first-page":"13147","DOI":"10.1021\/acsnano.2c11904","article-title":"Insights into the structure of Comirnaty COVID-19 vaccine: a theory on soft, partially bilayer-covered nanoparticles with hydrogen bond-stabilized mRNA-lipid complexes","volume":"17","author":"Szebeni","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2026.07.001_bib39","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jcis.2024.06.158","article-title":"The vast majority of nucleic acid-loaded lipid nanoparticles contain cargo","volume":"674","author":"M\u00fcnter","year":"2024","journal-title":"J Colloid Interface Sci"},{"key":"10.1016\/j.apsb.2026.07.001_bib40","doi-asserted-by":"crossref","first-page":"5561","DOI":"10.1038\/s41467-022-33157-4","article-title":"Payload distribution and capacity of mRNA lipid nanoparticles","volume":"13","author":"Li","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.07.001_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114082","article-title":"Structural characterization of mRNA lipid nanoparticles (LNPs) in the presence of mRNA-free LNPs","volume":"386","author":"Chen","year":"2025","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2026.07.001_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2024.114222","article-title":"Kinetics of RNA-LNP delivery and protein expression","volume":"197","author":"M\u00fcller","year":"2024","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.apsb.2026.07.001_bib43","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1021\/acsami.4c20077","article-title":"Transfection potency of lipid nanoparticles containing mRNA depends on relative loading levels","volume":"17","author":"Liao","year":"2025","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.apsb.2026.07.001_bib44","article-title":"Lipid nanoparticle protein coronas form via lipoprotein fusion rather than shell-like adsorption","author":"Grumelot","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.apsb.2026.07.001_bib45","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3389\/fbioe.2020.00166","article-title":"Recent advances in understanding the protein corona of nanoparticles and in the formulation of \u201cstealthy\u201d nanomaterials","volume":"8","author":"Rampado","year":"2020","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.apsb.2026.07.001_bib46","first-page":"757","article-title":"Protein corona of nanoparticles: isolation and analysis","volume":"1","author":"Sun","year":"2024","journal-title":"Chem Bioeng"},{"key":"10.1016\/j.apsb.2026.07.001_bib47","doi-asserted-by":"crossref","first-page":"8699","DOI":"10.1038\/s41467-025-63726-2","article-title":"Protein corona formed on lipid nanoparticles compromises delivery efficiency of mRNA cargo","volume":"16","author":"Voke","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.07.001_bib48","doi-asserted-by":"crossref","first-page":"6709","DOI":"10.1021\/acsnano.0c10064","article-title":"Apolipoprotein E binding drives structural and compositional rearrangement of mRNA-containing lipid nanoparticles","volume":"15","author":"Sebastiani","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2026.07.001_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114635","article-title":"Protein corona: friend or foe? Co-opting serum proteins for nanoparticle delivery","volume":"192","author":"Kim","year":"2023","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.apsb.2026.07.001_bib50","doi-asserted-by":"crossref","first-page":"10025","DOI":"10.1021\/acs.nanolett.2c03741","article-title":"The extent to which lipid nanoparticles require apolipoprotein E and low-density lipoprotein receptor for delivery changes with ionizable lipid structure","volume":"22","author":"Paunovska","year":"2022","journal-title":"Nano Lett"},{"key":"10.1016\/j.apsb.2026.07.001_bib51","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s40262-022-01149-8","article-title":"Establishing the pharmacokinetics of genetic vaccines is essential for maximising their safety and efficacy","volume":"61","author":"Naasani","year":"2022","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.apsb.2026.07.001_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2025.101436","article-title":"Why do lipid nanoparticles target the liver? Understanding of biodistribution and liver-specific tropism","volume":"33","author":"Hosseini-Kharat","year":"2025","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.apsb.2026.07.001_bib53","series-title":"Comirnaty: european public assessment report. EMEA\/H\/C\/005735\/0000","year":"2020"},{"key":"10.1016\/j.apsb.2026.07.001_bib54","series-title":"Nonclinical evaluation report BNT162b2 [mRNA] COVID-19 vaccine (Comirnaty). Freedom of Information Document FOI 2389-06","year":"2021"},{"key":"10.1016\/j.apsb.2026.07.001_bib55","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jcis.2015.10.057","article-title":"Cellular uptake and transcytosis of lipid-based nanoparticles across the intestinal barrier: relevance for oral drug delivery","volume":"463","author":"Neves","year":"2016","journal-title":"J Colloid Interface Sci"},{"key":"10.1016\/j.apsb.2026.07.001_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114861","article-title":"Lipid nanoparticle-mediated drug delivery to the brain","volume":"197","author":"Khare","year":"2023","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.apsb.2026.07.001_bib57","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2309472120","article-title":"Combinatorial design of ionizable lipid nanoparticles for muscle-selective mRNA delivery with minimized off-target effects","volume":"120","author":"Chen","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2026.07.001_bib58","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.jconrel.2022.12.020","article-title":"Self-homing nanocarriers for mRNA delivery to the activated hepatic stellate cells in liver fibrosis","volume":"353","author":"Younis","year":"2023","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2026.07.001_bib59","doi-asserted-by":"crossref","first-page":"27077","DOI":"10.1021\/acsnano.4c11652","article-title":"Blood distribution of SARS-CoV-2 lipid nanoparticle mRNA vaccine in humans","volume":"18","author":"Kent","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2026.07.001_bib60","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.ymthe.2025.01.008","article-title":"Visualizing lipid nanoparticle trafficking for mRNA vaccine delivery in non-human primates","volume":"33","author":"Buckley","year":"2025","journal-title":"Mol Ther"},{"key":"10.1016\/j.apsb.2026.07.001_bib61","doi-asserted-by":"crossref","first-page":"7682","DOI":"10.1021\/acs.nanolett.5c00311","article-title":"Development of chemical tags for universal lipid nanoparticle visualization and tracking in 2D and 3D imaging","volume":"25","author":"Balcorta","year":"2025","journal-title":"Nano Lett"},{"key":"10.1016\/j.apsb.2026.07.001_bib62","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.3390\/biomedicines9101496","article-title":"Impact of protein corona on the biological identity of nanomedicine: understanding the fate of nanomaterials in the biological milieu","volume":"9","author":"Akhter","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.apsb.2026.07.001_bib63","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1039\/C6CS00636A","article-title":"Cellular uptake of nanoparticles: journey inside the cell","volume":"46","author":"Behzadi","year":"2017","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.apsb.2026.07.001_bib64","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s12551-020-00775-5","article-title":"Lipid nanoparticle technologies for the study of G protein-coupled receptors in lipid environments","volume":"12","author":"Lavington","year":"2020","journal-title":"Biophys Rev"},{"key":"10.1016\/j.apsb.2026.07.001_bib65","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2307800120","article-title":"Endosomal escape: a bottleneck for LNP-mediated therapeutics","volume":"121","author":"Chatterjee","year":"2024","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2026.07.001_bib66","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1021\/acsnano.7b07583","article-title":"Endosomal size and membrane leakiness influence proton sponge-based rupture of endosomal vesicles","volume":"12","author":"Vermeulen","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2026.07.001_bib67","doi-asserted-by":"crossref","first-page":"5354","DOI":"10.1038\/s41467-025-60959-z","article-title":"Cellular and biophysical barriers to lipid nanoparticle-mediated delivery of RNA to the cytosol","volume":"16","author":"Johansson","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.07.001_bib68","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1039\/D2SM00179A","article-title":"Tear of lipid membranes by nanoparticles","volume":"18","author":"Er-Rafik","year":"2022","journal-title":"Soft Matter"},{"key":"10.1016\/j.apsb.2026.07.001_bib69","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.actbio.2021.06.023","article-title":"From influenza to COVID-19: lipid nanoparticle mRNA vaccines at the frontiers of infectious diseases","volume":"131","author":"Pilkington","year":"2021","journal-title":"Acta Biomater"},{"key":"10.1016\/j.apsb.2026.07.001_bib70","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1261\/rna.079507.122","article-title":"Endosomal escape of RNA therapeutics: how do we solve this rate-limiting problem?.","volume":"29","author":"Dowdy","year":"2023","journal-title":"RNA"},{"key":"10.1016\/j.apsb.2026.07.001_bib71","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.ymthe.2018.03.010","article-title":"A novel amino lipid series for mRNA delivery: improved endosomal escape and sustained pharmacology and safety in non-human primates","volume":"26","author":"Sabnis","year":"2018","journal-title":"Mol Ther"},{"key":"10.1016\/j.apsb.2026.07.001_bib72","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1038\/s41467-019-12275-6","article-title":"Linkage between endosomal escape of LNP-mRNA and loading into EVs for transport to other cells","volume":"10","author":"Maugeri","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.07.001_bib73","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nbt.2612","article-title":"Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escape","volume":"31","author":"Gilleron","year":"2013","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.apsb.2026.07.001_bib74","doi-asserted-by":"crossref","first-page":"22989","DOI":"10.1021\/acsnano.4c04519","article-title":"Time-resolved inspection of ionizable lipid-facilitated lipid nanoparticle disintegration and cargo release at an early endosomal membrane mimic","volume":"18","author":"Aliakbarinodehi","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2026.07.001_bib75","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10213","article-title":"Cytosolic delivery of nucleic acids: the case of ionizable lipid nanoparticles","volume":"6","author":"Schlich","year":"2021","journal-title":"Bioeng Transl Med"},{"key":"10.1016\/j.apsb.2026.07.001_bib76","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202110137","article-title":"Endosomal escape of delivered mRNA from endosomal recycling tubules visualized at the nanoscale","volume":"221","author":"Paramasivam","year":"2022","journal-title":"J Cell Biol"},{"key":"10.1016\/j.apsb.2026.07.001_bib77","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nbt.2614","article-title":"Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling","volume":"31","author":"Sahay","year":"2013","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.apsb.2026.07.001_bib78","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41573-023-00859-3","article-title":"Strategies to reduce the risks of mRNA drug and vaccine toxicity","volume":"23","author":"Bitounis","year":"2024","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.apsb.2026.07.001_bib79","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1016\/j.ymthe.2022.04.011","article-title":"Pro-inflammatory concerns with lipid nanoparticles","volume":"30","author":"Moghimi","year":"2022","journal-title":"Mol Ther"},{"key":"10.1016\/j.apsb.2026.07.001_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114047","article-title":"The kinetics of endosomal disruption reveal differences in lipid nanoparticle induced cellular toxicity","volume":"386","author":"Bates","year":"2025","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2026.07.001_bib81","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2301067120","article-title":"Lipid nanoparticle topology regulates endosomal escape and delivery of RNA to the cytoplasm","volume":"120","author":"Zheng","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2026.07.001_bib82","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s11095-025-03890-8","article-title":"Mechanism of pH-sensitive amphiphilic endosomal escape of ionizable lipid nanoparticles for cytosolic nucleic acid delivery","volume":"42","author":"Lu","year":"2025","journal-title":"Pharm Res"},{"key":"10.1016\/j.apsb.2026.07.001_bib83","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/s41392-024-01888-z","article-title":"Cell\u2013cell communication: new insights and clinical implications","volume":"9","author":"Su","year":"2024","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.apsb.2026.07.001_bib84","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3390\/biomedicines12010059","article-title":"Biodistribution of RNA vaccines and of their products: evidence from human and animal studies","volume":"12","author":"Pateev","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.apsb.2026.07.001_bib85","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.3390\/biomedicines10071538","article-title":"Vaccine mRNA can be detected in blood at 15 days post-vaccination","volume":"10","author":"Fertig","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.apsb.2026.07.001_bib86","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrd4278","article-title":"mRNA-based therapeutics\u2013developing a new class of drugs","volume":"13","author":"Sahin","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.apsb.2026.07.001_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.125024","article-title":"Entrapment of lipid nanoparticles in peripheral endosomes but not lysosomes impairs intracellular trafficking and endosomal escape","volume":"669","author":"Cheng","year":"2025","journal-title":"Int J Pharm"},{"key":"10.1016\/j.apsb.2026.07.001_bib88","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/s41565-025-01974-5","article-title":"Limiting endosomal damage sensing reduces inflammation triggered by lipid nanoparticle endosomal escape","volume":"20","author":"Omo-Lamai","year":"2025","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.apsb.2026.07.001_bib89","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.4049\/jimmunol.2100637","article-title":"Cutting edge: circulating exosomes with COVID spike protein are induced by BNT162b2 (Pfizer-BioNTech) vaccination prior to development of antibodies: a novel mechanism for immune activation by mRNA vaccines","volume":"207","author":"Bansal","year":"2021","journal-title":"J Immunol"},{"key":"10.1016\/j.apsb.2026.07.001_bib90","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202206968","article-title":"Biodegradable cationic and ionizable cationic lipids: a roadmap for safer pharmaceutical excipients","volume":"19","author":"J\u00f6rgensen","year":"2023","journal-title":"Small"},{"key":"10.1016\/j.apsb.2026.07.001_bib91","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1080\/20415990.2025.2506977","article-title":"The role of excipients in lipid nanoparticle metabolism: implications for enhanced therapeutic effect","volume":"16","author":"Knaggs","year":"2025","journal-title":"Ther Deliv"},{"key":"10.1016\/j.apsb.2026.07.001_bib92","doi-asserted-by":"crossref","first-page":"4591","DOI":"10.1016\/j.apsb.2024.06.011","article-title":"Modeling on in vivo disposition and cellular transportation of RNA lipid nanoparticles via quantum mechanics\/physiologically-based pharmacokinetic approaches","volume":"14","author":"Wang","year":"2024","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2026.07.001_bib93","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s11671-020-03344-7","article-title":"Reactive oxygen species-related nanoparticle toxicity in the biomedical field","volume":"15","author":"Yu","year":"2020","journal-title":"Nanoscale Res Lett"},{"key":"10.1016\/j.apsb.2026.07.001_bib94","doi-asserted-by":"crossref","first-page":"6777","DOI":"10.1038\/s41467-021-26926-0","article-title":"A novel mechanism for the loss of mRNA activity in lipid nanoparticle delivery systems","volume":"12","author":"Packer","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.07.001_bib95","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s42003-024-06235-0","article-title":"Overcoming thermostability challenges in mRNA\u2013lipid nanoparticle systems with piperidine-based ionizable lipids","volume":"7","author":"Hashiba","year":"2024","journal-title":"Commun Biol"},{"key":"10.1016\/j.apsb.2026.07.001_bib96","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.cell.2025.01.005","article-title":"Cellular responses to RNA damage","volume":"188","author":"Cordes","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2026.07.001_bib97","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.jmb.2019.11.016","article-title":"Nucleic acid sensors and programmed cell death","volume":"432","author":"Maelfait","year":"2020","journal-title":"J Mol Biol"},{"key":"10.1016\/j.apsb.2026.07.001_bib98","article-title":"Oxidative stress and 4-hydroxy-2-nonenal (4-HNE): implications in the pathogenesis and treatment of aging-related diseases","volume":"2022","author":"Li","year":"2022","journal-title":"J Immunol Res"},{"key":"10.1016\/j.apsb.2026.07.001_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaip.2020.11.011","article-title":"Anti-PEG IgE in anaphylaxis associated with polyethylene glycol","volume":"9","author":"Zhou","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.apsb.2026.07.001_bib100","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.addr.2020.07.024","article-title":"Anti-PEG antibodies: properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals","volume":"154\u2013155","author":"Kozma","year":"2020","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.apsb.2026.07.001_bib101","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.3390\/pharmaceutics17081074","article-title":"Anti-PEG antibodies and their biological impact on PEGylated drugs: challenges and strategies for optimization","volume":"17","author":"Fu","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.apsb.2026.07.001_bib102","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.tox.2005.07.023","article-title":"Complement activation-related pseudoallergy: a new class of drug-induced acute immune toxicity","volume":"216","author":"Szebeni","year":"2005","journal-title":"Toxicology"},{"key":"10.1016\/j.apsb.2026.07.001_bib103","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/s41565-018-0273-1","article-title":"Roadmap and strategy for overcoming infusion reactions to nanomedicines","volume":"13","author":"Szebeni","year":"2018","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.apsb.2026.07.001_bib104","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s11357-021-00495-y","article-title":"A naturally hypersensitive porcine model may help understand the mechanism of COVID-19 mRNA vaccine-induced rare (pseudo) allergic reactions: complement activation as a possible contributing factor","volume":"44","author":"D\u00e9zsi","year":"2022","journal-title":"GeroScience"},{"key":"10.1016\/j.apsb.2026.07.001_bib105","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.3390\/ijms25073595","article-title":"mRNA-LNP COVID-19 vaccine lipids induce complement activation and production of proinflammatory cytokines: mechanisms, effects of complement inhibitors, and relevance to adverse reactions","volume":"25","author":"Bakos","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2026.07.001_bib106","doi-asserted-by":"crossref","first-page":"798","DOI":"10.3390\/pharmaceutics17060798","article-title":"Implications of anaphylaxis following mRNA-LNP vaccines: It is urgent to eliminate PEG and find alternatives","volume":"17","author":"Song","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.apsb.2026.07.001_bib107","series-title":"Onpattro: European Public Assessment Report. EMA\/554262\/2018","year":"2018"},{"key":"10.1016\/j.apsb.2026.07.001_bib108","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.3390\/vaccines12101148","article-title":"Recent advances in lipid nanoparticles and their safety concerns for mRNA delivery","volume":"12","author":"Wang","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.apsb.2026.07.001_bib109","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01699-24","article-title":"Lipid nanoparticles as adjuvant of norovirus VLP vaccine augment cellular and humoral immune responses in a TLR9- and type I IFN-dependent pathway","volume":"98","author":"Dai","year":"2024","journal-title":"J Virol"},{"key":"10.1016\/j.apsb.2026.07.001_bib110","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1038\/s41551-024-01256-w","article-title":"Amine headgroups in ionizable lipids drive immune responses to lipid nanoparticles by binding to the receptors TLR4 and CD1d","volume":"8","author":"Chaudhary","year":"2024","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.apsb.2026.07.001_bib111","doi-asserted-by":"crossref","first-page":"375","DOI":"10.31083\/j.rcm2311375","article-title":"Inclisiran: a new pharmacological approach for hypercholesterolemia","volume":"23","author":"Di Fusco","year":"2022","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.apsb.2026.07.001_bib112","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1016\/j.jacc.2023.10.007","article-title":"Safety and tolerability of inclisiran for treatment of hypercholesterolemia in 7 clinical trials","volume":"82","author":"Wright","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.apsb.2026.07.001_bib113","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s40120-020-00208-1","article-title":"A review of patisiran (ONPATTRO\u00ae) for the treatment of polyneuropathy in people with hereditary transthyretin amyloidosis","volume":"9","author":"Urits","year":"2020","journal-title":"Neurol Ther"},{"key":"10.1016\/j.apsb.2026.07.001_bib114","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3390\/vaccines9040359","article-title":"Lipid-based nanoparticles in the clinic and clinical trials: from cancer nanomedicine to COVID-19 vaccines","volume":"9","author":"Thi","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.apsb.2026.07.001_bib115","series-title":"Kostaive (zapomeran): european public assessment report. Sections 2.4.3 (pharmacokinetics) and 2.4.6 (discussion on non-clinical aspects)","year":"2024"},{"key":"10.1016\/j.apsb.2026.07.001_bib116","series-title":"COVID-19 Vaccine Moderna: european public assessment report. EMEA\/H\/C\/005791\/0000","year":"2021"},{"key":"10.1016\/j.apsb.2026.07.001_bib117","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1016\/S0140-6736(22)00791-7","article-title":"Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA: a cohort study in claims databases","volume":"399","author":"Wong","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.apsb.2026.07.001_bib118","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.cell.2015.08.027","article-title":"Pathogen cell-to-cell variability drives heterogeneity in host immune responses","volume":"162","author":"Avraham","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2026.07.001_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103479","article-title":"The mRNA-LNP platform's lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory","volume":"24","author":"Ndeupen","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.apsb.2026.07.001_bib120","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/BF00295156","article-title":"The median lethal dose and its estimation","volume":"56","author":"Finney","year":"1985","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.apsb.2026.07.001_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2020.104662","article-title":"An FDA\/CDER perspective on nonclinical testing strategies: classical toxicology approaches and new approach methodologies (NAMs)","volume":"114","author":"Avila","year":"2020","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1016\/j.apsb.2026.07.001_bib122","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0952-7915(01)00308-9","article-title":"The role of chemokines in linking innate and adaptive immunity","volume":"14","author":"Luster","year":"2002","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.apsb.2026.07.001_bib123","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.0022-202X.2005.23841.x","article-title":"Chemokines: key players in innate and adaptive immunity","volume":"125","author":"Esche","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.apsb.2026.07.001_bib124","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.117090","article-title":"The multiple roles of GM-CSF in autoimmune and autoinflammatory uveitis","volume":"240","author":"Tao","year":"2025","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.apsb.2026.07.001_bib125","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1084\/jem.185.3.461","article-title":"Interleukin (IL)-6 directs the differentiation of IL-4-producing CD4+ T cells","volume":"185","author":"Rinc\u00f3n","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/j.apsb.2026.07.001_bib126","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/eji.201747037","article-title":"Functional and phenotypical analysis of IL-6-secreting CD4+ T cells in human adipose tissue","volume":"48","author":"de Jong","year":"2018","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.apsb.2026.07.001_bib127","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.coi.2008.04.013","article-title":"Pattern recognition receptors in the immune response against dying cells","volume":"20","author":"Jeannin","year":"2008","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.apsb.2026.07.001_bib128","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.immuni.2006.04.008","article-title":"Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment","volume":"24","author":"Nagai","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.apsb.2026.07.001_bib129","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.chom.2014.05.017","article-title":"Nod-like receptors have a grip on stem cells","volume":"15","author":"Fritz","year":"2014","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.apsb.2026.07.001_bib130","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.semcancer.2020.12.016","article-title":"LRIG1, a regulator of stem cell quiescence and a pleiotropic feedback tumor suppressor","volume":"82","author":"Ji","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.apsb.2026.07.001_bib131","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jconrel.2021.12.027","article-title":"Added to pre-existing inflammation, mRNA-lipid nanoparticles induce inflammation exacerbation (IE)","volume":"344","author":"Parhiz","year":"2022","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2026.07.001_bib132","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41541-025-01124-x","article-title":"Ionizable lipid nanoparticles of mRNA vaccines elicit NF-\u03baB and IRF responses through toll-like receptor 4","volume":"10","author":"Zelkoski","year":"2025","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.apsb.2026.07.001_bib133","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1007\/s00018-017-2520-2","article-title":"Advances in anti-viral immune defense: revealing the importance of the IFN JAK\/STAT pathway","volume":"74","author":"Raftery","year":"2017","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.apsb.2026.07.001_bib134","doi-asserted-by":"crossref","first-page":"24842","DOI":"10.1021\/acsnano.4c05088","article-title":"Lipid nanoparticles elicit reactogenicity and sickness behavior in mice via toll-like receptor 4 and myeloid differentiation protein 88 axis","volume":"18","author":"Korzun","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2026.07.001_bib135","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.tibs.2011.03.006","article-title":"The Ras\u2013ERK and PI3K\u2013mTOR pathways: cross-talk and compensation","volume":"36","author":"Mendoza","year":"2011","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.apsb.2026.07.001_bib136","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3390\/genes12060819","article-title":"The crossroads between RAS and RHO signaling pathways in cellular transformation, motility and contraction","volume":"12","author":"Soriano","year":"2021","journal-title":"Genes"},{"key":"10.1016\/j.apsb.2026.07.001_bib137","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1038\/s41587-024-02528-1","article-title":"Nanocarrier imaging at single-cell resolution across entire mouse bodies with deep learning","volume":"43","author":"Luo","year":"2025","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.apsb.2026.07.001_bib138","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s43856-022-00083-x","article-title":"BNT162b2 vaccination enhances interferon\u2013JAK\u2013STAT-regulated antiviral programs in COVID-19 patients infected with the SARS-CoV-2 Beta variant","volume":"2","author":"Knabl","year":"2022","journal-title":"Commun Med"},{"key":"10.1016\/j.apsb.2026.07.001_bib139","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1502458","article-title":"Proteomic and serologic assessments of responses to mRNA-1273 and BNT162b2 vaccines in human recipient sera","volume":"15","author":"Hickey","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2026.07.001_bib140","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41392-023-01608-z","article-title":"Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease","volume":"8","author":"Panwar","year":"2023","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.apsb.2026.07.001_bib141","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41392-020-00312-6","article-title":"Targeting NF-\u03baB pathway for the therapy of diseases: mechanism and clinical study","volume":"5","author":"Yu","year":"2020","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.apsb.2026.07.001_bib142","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","article-title":"NF-\u03baB in biology and targeted therapy: new insights and translational implications","volume":"9","author":"Guo","year":"2024","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.apsb.2026.07.001_bib143","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.bbamcr.2013.02.028","article-title":"The ubiquitin proteasome system\u2014implications for cell cycle control and the targeted treatment of cancer","volume":"1843","author":"Bassermann","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.apsb.2026.07.001_bib144","series-title":"StatPearls [Internet]","article-title":"Corticosteroid Adverse effects. [Updated 2023 Jul 3]","author":"Yasir","year":"2026"},{"key":"10.1016\/j.apsb.2026.07.001_bib145","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1002\/jcb.26066","article-title":"Cytokinetic abscission: phosphoinositides and ESCRTs direct the final cut","volume":"118","author":"Gulluni","year":"2017","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.apsb.2026.07.001_bib146","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1242\/jcs.175208","article-title":"Emerging roles of PtdIns(4,5)P2\u2014beyond the plasma membrane","volume":"128","author":"Tan","year":"2015","journal-title":"J Cell Sci"},{"key":"10.1016\/j.apsb.2026.07.001_bib147","doi-asserted-by":"crossref","DOI":"10.1016\/j.devcel.2021.08.019","article-title":"Endosomal trafficking and DNA damage checkpoint kinases dictate survival to replication stress by regulating amino acid uptake and protein synthesis","volume":"56","author":"Ajazi","year":"2021","journal-title":"Dev Cell"},{"key":"10.1016\/j.apsb.2026.07.001_bib148","article-title":"The interplay between phosphoinositides and ESCRT proteins","volume":"9","author":"Giannini","year":"2025","journal-title":"Adv Bio Regul"},{"key":"10.1016\/j.apsb.2026.07.001_bib149","doi-asserted-by":"crossref","first-page":"5566","DOI":"10.1039\/D2BM00883A","article-title":"mRNA-carrying lipid nanoparticles that induce lysosomal rupture activate NLRP3 inflammasome and reduce mRNA transfection efficiency","volume":"10","author":"Forster","year":"2022","journal-title":"Biomater Sci"},{"key":"10.1016\/j.apsb.2026.07.001_bib150","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/s41586-025-08950-y","article-title":"The expanding repertoire of ESCRT functions in cell biology and disease","volume":"642","author":"Hurley","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2026.07.001_bib151","doi-asserted-by":"crossref","first-page":"8542","DOI":"10.1021\/ja4003525","article-title":"Characterizing the membrane-bound state of cytochrome P450 3A4: structure, depth of insertion, and orientation","volume":"135","author":"Baylon","year":"2013","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.apsb.2026.07.001_bib152","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.RA117.000961","article-title":"Membrane-embedded substrate recognition by cytochrome P450 3A4","volume":"293","author":"Hackett","year":"2018","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2026.07.001_bib153","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s42003-020-01568-y","article-title":"An electron transfer competent structural ensemble of membrane-bound cytochrome P450 1A1 and cytochrome P450 oxidoreductase","volume":"4","author":"Mukherjee","year":"2021","journal-title":"Commun Biol"},{"key":"10.1016\/j.apsb.2026.07.001_bib154","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s13318-023-00852-6","article-title":"Unraveling the effects of acute inflammation on pharmacokinetics: a model-based analysis focusing on renal glomerular filtration rate and cytochrome P450 3A4-mediated metabolism","volume":"48","author":"Liu","year":"2023","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1016\/j.apsb.2026.07.001_bib155","doi-asserted-by":"crossref","first-page":"107627","DOI":"10.1016\/j.pharmthera.2020.107627","article-title":"French Society of Pharmacology and Therapeutics. Inflammation is a major regulator of drug metabolizing enzymes and transporters: consequences for the personalization of drug treatment","volume":"215","author":"Stanke-Labesque","year":"2020","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.apsb.2026.07.001_bib156","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jcrc.2019.12.009","article-title":"C-reactive protein as a prognostic factor in intensive care admissions for sepsis: a Swedish multicenter study","volume":"56","author":"Koozi","year":"2020","journal-title":"J Crit Care"},{"key":"10.1016\/j.apsb.2026.07.001_bib157","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.14441","article-title":"The potential interaction between COVID-19 vaccines and clozapine: a novel approach for clinical trials","volume":"75","author":"Bayraktar","year":"2021","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.apsb.2026.07.001_bib158","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/npr2.12238","article-title":"A case report: clozapine-induced leukopenia and neutropenia after mRNA COVID-19 vaccination","volume":"42","author":"Imai","year":"2022","journal-title":"Neuropsychopharmacol Rep"},{"key":"10.1016\/j.apsb.2026.07.001_bib159","doi-asserted-by":"crossref","first-page":"E210","DOI":"10.1503\/jpn.210027","article-title":"Elevated clozapine levels and toxic effects after SARS-CoV-2 vaccination","volume":"46","author":"Thompson","year":"2021","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.apsb.2026.07.001_bib160","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1046\/j.1365-2125.1997.t01-1-00605.x","article-title":"The involvement of CYP1A2 and CYP3A4 in the metabolism of clozapine","volume":"44","author":"Eiermann","year":"1997","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.apsb.2026.07.001_bib161","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1080\/17425255.2023.2228680","article-title":"The impact of COVID-19 infection on cytochrome P450 3A4-mediated drug metabolism and drug interactions","volume":"19","author":"Villemure","year":"2023","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.apsb.2026.07.001_bib162","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s13318-023-00826-8","article-title":"Role of cytochrome P450 2C9 in COVID-19 treatment: current status and future directions","volume":"48","author":"Lim","year":"2023","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1016\/j.apsb.2026.07.001_bib163","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.3390\/biomedicines12071467","article-title":"Decoding the role of CYP450 enzymes in metabolism and disease: a comprehensive review","volume":"12","author":"Hossam","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.apsb.2026.07.001_bib164","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcis.2025.139420","article-title":"Rapid structural transformation of ionizable lipid nanoparticles involving omega-3 polyunsaturated fatty acids enhances antioxidant defense and mitochondrial proteins activity in pH-responsive drug delivery","volume":"704","author":"Akanchise","year":"2026","journal-title":"J Colloid Interface Sci"},{"key":"10.1016\/j.apsb.2026.07.001_bib165","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1016\/j.bbamem.2015.03.014","article-title":"Role of lipid microdomains in TLR-Mediated signalling","volume":"1848","author":"Ruysschaert","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.apsb.2026.07.001_bib166","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.bcp.2008.10.029","article-title":"TLR4-dependent and -independent regulation of hepatic cytochrome P450 in mice with chemically induced inflammatory bowel disease","volume":"77","author":"Chaluvadi","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.apsb.2026.07.001_bib167","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1021\/acsnano.2c06213","article-title":"Acidification-induced structure evolution of lipid nanoparticles correlates with their in vitro gene transfections","volume":"17","author":"Li","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2026.07.001_bib168","doi-asserted-by":"crossref","first-page":"15377","DOI":"10.1021\/bi035280k","article-title":"Membrane properties induced by anionic phospholipids and phosphatidylethanolamine are critical for the membrane binding and catalytic activity of human cytochrome P450 3A4","volume":"42","author":"Kim","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.apsb.2026.07.001_bib169","doi-asserted-by":"crossref","first-page":"7284","DOI":"10.1038\/s41598-020-64129-7","article-title":"The effect of force-field parameters on cytochrome P450-membrane interactions: structure and dynamics","volume":"10","author":"Mustafa","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2026.07.001_bib170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011566","article-title":"Function and regulation of a steroidogenic CYP450 enzyme in the mitochondrion of Toxoplasma gondii","volume":"19","author":"Asady","year":"2023","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.apsb.2026.07.001_bib171","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000046221","article-title":"Association between coronavirus disease 2019 vaccination and hypercholesterolemia: a cross-sectional study from the 2023 National Health Interview Survey","volume":"104","author":"Huang","year":"2025","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.apsb.2026.07.001_bib172","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.1038\/ncomms5407","article-title":"Rab8a interacts directly with PI3K\u03b3 to modulate TLR4-driven PI3K and mTOR signalling","volume":"5","author":"Luo","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.07.001_bib173","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1189\/jlb.2VMA1215-577R","article-title":"Contribution of CD14 and TLR4 to changes of the PI(4,5)P2 level in LPS-stimulated cells","volume":"100","author":"P\u0142\u00f3ciennikowska","year":"2016","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.apsb.2026.07.001_bib174","doi-asserted-by":"crossref","first-page":"28251","DOI":"10.1073\/pnas.2001948117","article-title":"Phosphatidylinositol-4-kinase II\u03b1 licenses phagosomes for TLR4 signaling and MHC-II presentation in dendritic cells","volume":"117","author":"L\u00f3pez-Haber","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2026.07.001_bib175","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12951-025-03800-5","article-title":"mRNA vaccines: immunogenicity and quality characteristics","volume":"24","author":"Quan","year":"2025","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.apsb.2026.07.001_bib176","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a041418","article-title":"Cholesterol, eukaryotic lipid domains, and an evolutionary perspective of transmembrane signaling","volume":"15","author":"Shi","year":"2023","journal-title":"Cold Spring Harbor Perspect Biol"},{"key":"10.1016\/j.apsb.2026.07.001_bib177","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/1753425919852695","article-title":"Lipids that directly regulate innate immune signal transduction","volume":"26","author":"Barnett","year":"2019","journal-title":"Innate Immun"},{"key":"10.1016\/j.apsb.2026.07.001_bib178","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/385352","article-title":"TNF\u03b1 promotes Th17 cell differentiation through IL-6 and IL-1\u03b2 produced by monocytes in rheumatoid arthritis","volume":"2014","author":"Zheng","year":"2014","journal-title":"J Immunol Res"},{"key":"10.1016\/j.apsb.2026.07.001_bib179","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.2337\/db17-1280","article-title":"Interleukin-6 reduces \u03b2-cell oxidative stress by linking autophagy with the antioxidant response","volume":"67","author":"Marasco","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.apsb.2026.07.001_bib180","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/nri3532","article-title":"Autophagy in infection, inflammation and immunity","volume":"13","author":"Deretic","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.apsb.2026.07.001_bib181","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-2172-5-22","article-title":"MAPK-dependent regulation of IL-1- and beta-adrenoreceptor-induced inflammatory cytokine production from mast cells: implications for the stress response","volume":"5","author":"Chi","year":"2004","journal-title":"BMC Immunol"},{"key":"10.1016\/j.apsb.2026.07.001_bib182","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.cellsig.2007.10.025","article-title":"IL-1beta-stimulated activation of ERK1\/2 and p38alpha MAPK mediates the transcriptional up-regulation of IL-6, IL-8 and GRO-alpha in HeLa cells","volume":"20","author":"Yang","year":"2008","journal-title":"Cell Signal"},{"key":"10.1016\/j.apsb.2026.07.001_bib183","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.661323","article-title":"Tumor NLRP3-derived IL-1\u03b2 drives the IL-6\/STAT3 axis resulting in sustained MDSC-mediated immunosuppression","volume":"12","author":"Tengesdal","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2026.07.001_bib184","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.147","article-title":"Role of chemokine systems in cancer and inflammatory diseases","volume":"3","author":"Li","year":"2022","journal-title":"MedComm"},{"key":"10.1016\/j.apsb.2026.07.001_bib185","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cytogfr.2019.05.010","article-title":"Macrophage chemoattractants secreted by cancer cells: sculptors of the tumor microenvironment and another crucial piece of the cancer secretome as a therapeutic target","volume":"50","author":"Unver","year":"2019","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.apsb.2026.07.001_bib186","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1016\/j.celrep.2017.11.014","article-title":"Noncanonical pathway for regulation of CCL2 expression by an mTORC1-FOXK1 axis promotes recruitment of tumor-associated macrophages","volume":"21","author":"Nakatsumi","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.apsb.2026.07.001_bib187","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jcmgh.2022.04.003","article-title":"Senescence connects autophagy deficiency to inflammation and tumor progression in the liver","volume":"14","author":"Huda","year":"2022","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.apsb.2026.07.001_bib188","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.785457","article-title":"Role of CXCL5 in regulating chemotaxis of innate and adaptive leukocytes in infected lungs upon pulmonary influenza infection","volume":"12","author":"Guo","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2026.07.001_bib189","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.plipres.2011.03.002","article-title":"Role of membrane integrity on G protein-coupled receptors: rhodopsin stability and function","volume":"50","author":"Jastrzebska","year":"2011","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.apsb.2026.07.001_bib190","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.chemphyslip.2016.04.006","article-title":"Interaction of G protein-coupled receptors and cholesterol","volume":"199","author":"Gimpl","year":"2016","journal-title":"Chem Phys Lipids"},{"key":"10.1016\/j.apsb.2026.07.001_bib191","doi-asserted-by":"crossref","DOI":"10.1038\/srep31858","article-title":"Cholesterol-dependent conformational plasticity in GPCR dimers","volume":"6","author":"Prasanna","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2026.07.001_bib192","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemphyslip.2019.104852","article-title":"Role of cholesterol-mediated effects in GPCR heterodimers","volume":"227","author":"Prasanna","year":"2020","journal-title":"Chem Phys Lipids"},{"key":"10.1016\/j.apsb.2026.07.001_bib193","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s12551-021-00878-7","article-title":"Cholesterol-dependent endocytosis of GPCRs: implications in pathophysiology and therapeutics","volume":"13","author":"Kumar","year":"2021","journal-title":"Biophys Rev"},{"key":"10.1016\/j.apsb.2026.07.001_bib194","doi-asserted-by":"crossref","DOI":"10.1016\/j.str.2023.05.001","article-title":"Dual mechanisms of cholesterol-GPCR interactions that depend on membrane phospholipid composition","volume":"31","author":"Ray","year":"2023","journal-title":"Structure"},{"key":"10.1016\/j.apsb.2026.07.001_bib195","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1466264","article-title":"Vitronectin promotes proliferation and metastasis of cervical cancer cells via the epithelial-mesenchymal transition","volume":"14","author":"Lin","year":"2024","journal-title":"Front Oncol"},{"key":"10.1016\/j.apsb.2026.07.001_bib196","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1186\/s12967-024-05894-1","article-title":"Ficolin-1 ameliorates pulmonary fibrosis via directly binding to TGF-\u03b21","volume":"22","author":"Gao","year":"2024","journal-title":"J Transl Med"},{"key":"10.1016\/j.apsb.2026.07.001_bib197","doi-asserted-by":"crossref","first-page":"G739","DOI":"10.1152\/ajpgi.00432.2010","article-title":"Activated AMPK inhibits PPAR-\u03b1 and PPAR-\u03b3 transcriptional activity in hepatoma cells","volume":"301","author":"Sozio","year":"2011","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.apsb.2026.07.001_bib198","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1159\/000478920","article-title":"Interactions of TLR4 and PPAR\u03b3, dependent on AMPK signalling pathway contribute to anti-inflammatory effects of vaccariae hypaphorine in endothelial cells","volume":"42","author":"Sun","year":"2017","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.apsb.2026.07.001_bib199","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1002\/hep.20705","article-title":"Th1 cytokine-induced downregulation of PPAR\u03b3 in human biliary cells relates to cholangitis in primary biliary cirrhosis","volume":"41","author":"Harada","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2026.07.001_bib200","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/j.1745-7254.2006.00359.x","article-title":"PPAR\u03b3 phosphorylation mediated by JNK MAPK: a potential role in macrophage-derived foam cell formation","volume":"27","author":"Yin","year":"2006","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.apsb.2026.07.001_bib201","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1089\/dna.2022.0087","article-title":"The regulation of autophagy by p38 MAPK-PPAR\u03b3 signaling during the brain ischemic tolerance induced by cerebral ischemic preconditioning","volume":"41","author":"Su","year":"2022","journal-title":"DNA Cell Biol"},{"key":"10.1016\/j.apsb.2026.07.001_bib202","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.3390\/cells11203215","article-title":"PPAR\u03b3 partial agonists in disease-fate decision with special reference to cancer","volume":"11","author":"Ballav","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.apsb.2026.07.001_bib203","doi-asserted-by":"crossref","first-page":"954","DOI":"10.18632\/oncotarget.652","article-title":"Mutations and deregulation of Ras\/Raf\/MEK\/ERK and PI3K\/PTEN\/Akt\/mTOR cascades which alter therapy response","volume":"3","author":"McCubrey","year":"2012","journal-title":"Oncotarget"},{"key":"10.1016\/j.apsb.2026.07.001_bib204","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.3390\/cells14151207","article-title":"Reactive oxygen species: a double-edged sword in the modulation of cancer signaling pathway dynamics","volume":"14","author":"Nigam","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.apsb.2026.07.001_bib205","doi-asserted-by":"crossref","first-page":"13578","DOI":"10.1074\/jbc.M211584200","article-title":"RhoA and ROCK promote migration by limiting membrane protrusions","volume":"278","author":"Worthylake","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2026.07.001_bib206","doi-asserted-by":"crossref","first-page":"44756","DOI":"10.1074\/jbc.M402292200","article-title":"Cell type-specific regulation of RhoA activity during cytokinesis","volume":"279","author":"Yoshizaki","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2026.07.001_bib207","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1111\/j.1742-4658.2009.06928.x","article-title":"Compartmentalized signalling: ras proteins and signalling nanoclusters","volume":"276","author":"Omerovic","year":"2009","journal-title":"FEBS J"},{"key":"10.1016\/j.apsb.2026.07.001_bib208","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.cell.2014.02.051","article-title":"KRas localizes to the plasma membrane by spatial cycles of solubilization, trapping and vesicular transport","volume":"157","author":"Schmick","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2026.07.001_bib209","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2014605118","article-title":"The KRAS and other prenylated polybasic domain membrane anchors recognize phosphatidylserine acyl chain structure","volume":"118","author":"Zhou","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.apsb.2026.07.001_bib210","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.devcel.2019.05.042","article-title":"Anillin puts RhoA in touch with PIP2","volume":"49","author":"Munro","year":"2019","journal-title":"Dev Cell"},{"key":"10.1016\/j.apsb.2026.07.001_bib211","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20050231","article-title":"Ras plasma membrane signalling platforms","volume":"389","author":"Hancock","year":"2005","journal-title":"Biochem J"},{"key":"10.1016\/j.apsb.2026.07.001_bib212","doi-asserted-by":"crossref","first-page":"9465","DOI":"10.1074\/jbc.M114.620724","article-title":"Mechanisms of membrane binding of small GTPase K-Ras4B farnesylated hypervariable region","volume":"290","author":"Jang","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2026.07.001_bib213","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212493","article-title":"Electrostatic forces mediate the specificity of RHO GTPase-GDI interactions","volume":"22","author":"Mosaddeghzadeh","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2026.07.001_bib214","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2022.212918","article-title":"Electrical stimulation: effective cue to direct osteogenic differentiation of mesenchymal stem cells?.","volume":"138","author":"Guillot-Ferriols","year":"2022","journal-title":"Biomater Adv"},{"key":"10.1016\/j.apsb.2026.07.001_bib215","doi-asserted-by":"crossref","DOI":"10.1016\/j.matdes.2026.115501","article-title":"Engineered smart piezoelectric materials facilitate bone defect regeneration","volume":"262","author":"Chen","year":"2026","journal-title":"Mater Des"},{"key":"10.1016\/j.apsb.2026.07.001_bib216","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.21037\/tcr-21-45","article-title":"E2F1\/2\/4 mRNA is associated with immune infiltration and are potential biomarkers for the prognosis of human gastric carcinoma","volume":"10","author":"Chen","year":"2021","journal-title":"Transl Cancer Res"},{"key":"10.1016\/j.apsb.2026.07.001_bib217","doi-asserted-by":"crossref","first-page":"9181","DOI":"10.1038\/s41467-024-52820-6","article-title":"Uncoupling of mTORC1 from E2F activity maintains DNA damage and senescence","volume":"15","author":"Daigh","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.07.001_bib218","first-page":"1707","article-title":"E2F1-mediated GINS2 transcriptional activation promotes tumor progression through PI3K\/AKT\/mTOR pathway in hepatocellular carcinoma","volume":"12","author":"Zhang","year":"2022","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.apsb.2026.07.001_bib219","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/msb.2008.7","article-title":"A comprehensive modular map of molecular interactions in RB\/E2F pathway","volume":"4","author":"Calzone","year":"2008","journal-title":"Mol Syst Biol"},{"key":"10.1016\/j.apsb.2026.07.001_bib220","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.7187","article-title":"E2F transcription factors promote tumorigenicity in pancreatic ductal adenocarcinoma","volume":"13","author":"Bertonnier-Brouty","year":"2024","journal-title":"Cancer Med"},{"key":"10.1016\/j.apsb.2026.07.001_bib221","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1091\/mbc.E19-12-0725","article-title":"Cell cycle oscillators underlying orderly proteolysis of E2F8","volume":"31","author":"Wasserman","year":"2020","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.apsb.2026.07.001_bib222","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1128\/MCB.02147-06","article-title":"E2f1, E2f2, and E2f3 control E2F target expression and cellular proliferation via a p53-dependent negative feedback loop","volume":"27","author":"Timmers","year":"2007","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.apsb.2026.07.001_bib223","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1470368","article-title":"E2F1-induced autocrine IL-6 inflammatory loop mediates cancer-immune crosstalk that predicts T cell phenotype switching and therapeutic responsiveness","volume":"15","author":"Spitschak","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2026.07.001_bib224","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.devcel.2007.10.017","article-title":"Synergistic function of E2F7 and E2F8 is essential for cell survival and embryonic development","volume":"14","author":"Li","year":"2008","journal-title":"Dev Cell"},{"key":"10.1016\/j.apsb.2026.07.001_bib225","article-title":"Transcription factor E2F8 is a therapeutic target in the basal-like subtype of breast cancer","volume":"13","author":"Zheng","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.apsb.2026.07.001_bib226","doi-asserted-by":"crossref","first-page":"6379","DOI":"10.1128\/MCB.19.9.6379","article-title":"CDC25A phosphatase is a target of E2F and is required for efficient E2F-induced S phase","volume":"19","author":"Vigo","year":"1999","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.apsb.2026.07.001_bib227","doi-asserted-by":"crossref","first-page":"24949","DOI":"10.1021\/acsomega.1c03936","article-title":"Phosphoproteomics provides novel insights into the response of primary acute lymphoblastic leukemia cells to microtubule depolymerization in G1 phase of the cell cycle","volume":"6","author":"Delgado","year":"2021","journal-title":"ACS Omega"},{"key":"10.1016\/j.apsb.2026.07.001_bib228","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3389\/fimmu.2015.00117","article-title":"Lipid and protein co-regulation of PI3K effectors Akt and Itk in lymphocytes","volume":"6","author":"Wang","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2026.07.001_bib229","article-title":"Gradients of PI(4,5)P2 and PI(3,5)P2 jointly participate in shaping the back state of dictyostelium cells","volume":"10","author":"Sun","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.apsb.2026.07.001_bib230","article-title":"PI(3,5)P2 controls the signaling activity of class I PI3K","author":"Sun","year":"2025","journal-title":"bioRxiv [Preprint]"},{"key":"10.1016\/j.apsb.2026.07.001_bib231","doi-asserted-by":"crossref","first-page":"802","DOI":"10.3390\/biom12060802","article-title":"The translational regulation in mTOR Pathway","volume":"12","author":"Yang","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.apsb.2026.07.001_bib232","doi-asserted-by":"crossref","first-page":"5160","DOI":"10.1128\/MCB.00448-10","article-title":"Regulation of eukaryotic initiation factor 4E (eIF4E) phosphorylation by mitogen-activated protein kinase occurs through modulation of Mnk1\u2013eIF4G interaction","volume":"30","author":"Shveygert","year":"2010","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.apsb.2026.07.001_bib233","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010830","article-title":"Pre-exposure to mRNA-LNP inhibits adaptive immune responses and alters innate immune fitness in an inheritable fashion","volume":"18","author":"Qin","year":"2022","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.apsb.2026.07.001_bib234","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.plipres.2008.03.002","article-title":"Cationic liposomal lipids: from gene carriers to cell signaling","volume":"47","author":"Lonez","year":"2008","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.apsb.2026.07.001_bib235","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.addr.2012.05.009","article-title":"Cationic lipids activate intracellular signaling pathways","volume":"64","author":"Lonez","year":"2012","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.apsb.2026.07.001_bib236","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/s42003-023-04555-1","article-title":"Lipid nanoparticles (LNP) induce activation and maturation of antigen presenting cells in young and aged individuals","volume":"6","author":"Connors","year":"2023","journal-title":"Commun Biol"},{"key":"10.1016\/j.apsb.2026.07.001_bib237","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202500622R","article-title":"Lipid nanoparticle: beyond delivery vehicle-unveiling its immunological adjuvant potential","volume":"39","author":"Amor","year":"2025","journal-title":"FASEB J"},{"key":"10.1016\/j.apsb.2026.07.001_bib238","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.163347","article-title":"Consecutive BNT162b2 mRNA vaccination induces short-term epigenetic memory in innate immune cells","volume":"7","author":"Yamaguchi","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.apsb.2026.07.001_bib239","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s44320-025-00093-6","article-title":"Persistent epigenetic memory of SARS-CoV-2 mRNA vaccination in monocyte-derived macrophages","volume":"21","author":"Simonis","year":"2025","journal-title":"Mol Syst Biol"},{"key":"10.1016\/j.apsb.2026.07.001_bib240","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12944-025-02452-6","article-title":"Plasma membrane and nuclear phosphatidylinositol 4,5-bisphosphate signalling in cancer","volume":"24","author":"Chyt\u0142a","year":"2025","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.apsb.2026.07.001_bib241","doi-asserted-by":"crossref","DOI":"10.1111\/boc.202400096","article-title":"Phosphoinositide signaling in the nucleus: impacts on chromatin and transcription regulation","volume":"117","author":"Hifdi","year":"2025","journal-title":"Biol Cell"},{"key":"10.1016\/j.apsb.2026.07.001_bib242","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1124\/dmd.122.000934","article-title":"COVID-19 Vaccines and the virus: impact on drug metabolism and pharmacokinetics","volume":"51","author":"McColl","year":"2023","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.apsb.2026.07.001_bib243","doi-asserted-by":"crossref","first-page":"6181","DOI":"10.1038\/s41467-024-50656-8","article-title":"Long-term risk of autoimmune diseases after mRNA-based SARS-CoV2 vaccination in a Korean, nationwide, population-based cohort study","volume":"15","author":"Jung","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.07.001_bib244","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1203755","article-title":"Editorial: molecular crosstalk between endocrine factors, paracrine signals, and the immune system during aging","volume":"14","author":"Sellegounder","year":"2023","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.apsb.2026.07.001_bib245","article-title":"Agonist- and stress-driven compartmentalized phosphoinositide signaling in cells","volume":"1870","author":"Chen","year":"2025","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"10.1016\/j.apsb.2026.07.001_bib246","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1083\/jcb.201610060","article-title":"Localization of mTORC2 activity inside cells","volume":"216","author":"Ebner","year":"2017","journal-title":"J Cell Biol"},{"key":"10.1016\/j.apsb.2026.07.001_bib247","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.mce.2017.04.025","article-title":"Crosstalk between STAT5 activation and PI3K\/AKT functions in normal and transformed mammary epithelial cells","volume":"451","author":"R\u00e4dler","year":"2017","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.apsb.2026.07.001_bib248","doi-asserted-by":"crossref","first-page":"760","DOI":"10.3390\/cells13090760","article-title":"JAK\/STAT inhibition normalizes lipid composition in 3D human epidermal equivalents challenged with Th2 cytokines","volume":"13","author":"Flori","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.apsb.2026.07.001_bib249","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3390\/biom12081033","article-title":"Nanoscopic spatial association between Ras and phosphatidylserine on the cell membrane studied with multicolor super resolution microscopy","volume":"12","author":"Koester","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.apsb.2026.07.001_bib250","first-page":"87","article-title":"The effect of nanoparticle uptake on cellular behavior: disrupting or enabling functions?.","volume":"5","author":"Panariti","year":"2012","journal-title":"Nanotechnol Sci Appl"},{"key":"10.1016\/j.apsb.2026.07.001_bib251","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1073\/pnas.1322356111","article-title":"Differential uptake of nanoparticles by endothelial cells through polyelectrolytes with affinity for caveolae","volume":"111","author":"Voigt","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2026.07.001_bib252","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1021\/nn203892h","article-title":"Cellular uptake of nanoparticles by membrane penetration: a study combining confocal microscopy with FTIR spectroelectrochemistry","volume":"6","author":"Wang","year":"2012","journal-title":"ACS Nano"},{"key":"10.1016\/j.apsb.2026.07.001_bib253","first-page":"37","article-title":"Chapter three: exploring interactions between lipid membranes and nanoparticles through neutron and X-ray reflectometry techniques","volume":"vol. 38","author":"Gerelli","year":"2023"},{"key":"10.1016\/j.apsb.2026.07.001_bib254","doi-asserted-by":"crossref","first-page":"9452","DOI":"10.1039\/D0NR00868K","article-title":"Size-dependent aggregation of hydrophobic nanoparticles in lipid membranes","volume":"12","author":"Lavagna","year":"2020","journal-title":"Nanoscale"},{"key":"10.1016\/j.apsb.2026.07.001_bib255","series-title":"The cell: a molecular approach","author":"Cooper","year":"2000"},{"key":"10.1016\/j.apsb.2026.07.001_bib256","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ceb.2019.12.007","article-title":"Novel roles of phosphoinositides in signaling, lipid transport, and disease","volume":"63","author":"Hammond","year":"2020","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.apsb.2026.07.001_bib257","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1038\/s41467-019-10711-1","article-title":"The role of PS 18: 0\/18: 1 in membrane function","volume":"10","author":"Skotland","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.07.001_bib258","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamem.2022.184104","article-title":"The excitable fluid mosaic","volume":"1865","author":"Heimburg","year":"2023","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"10.1016\/j.apsb.2026.07.001_bib259","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.bpj.2009.09.063","article-title":"A molecular dynamics investigation of lipid bilayer perturbation by PIP2","volume":"98","author":"Lupyan","year":"2010","journal-title":"Biophys J"},{"key":"10.1016\/j.apsb.2026.07.001_bib260","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1194\/jlr.R200021-JLR200","article-title":"Lipid rafts: bringing order to chaos","volume":"44","author":"Pike","year":"2003","journal-title":"J Lipid Res"},{"key":"10.1016\/j.apsb.2026.07.001_bib261","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.bbalip.2014.09.005","article-title":"Phosphoinositides in phagocytosis and macropinocytosis","volume":"1851","author":"Levin","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.apsb.2026.07.001_bib262","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/ncb811","article-title":"A PtdInsP(3)- and Rho GTPase-mediated positive feedback loop regulates neutrophil polarity","volume":"4","author":"Weiner","year":"2002","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.apsb.2026.07.001_bib263","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1011523","article-title":"Particle-based simulations reveal two positive feedback loops allow relocation and stabilization of the polarity site during yeast mating","volume":"19","author":"Guan","year":"2023","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.apsb.2026.07.001_bib264","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006604","article-title":"Lipid raft-mediated regulation of G-protein coupled receptor signaling by ligands which influence receptor dimerization: a computational study","volume":"4","author":"Fallahi-Sichani","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.apsb.2026.07.001_bib265","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125571","article-title":"Regulating mRNA endosomal escape through lipid rafts: a review","volume":"675","author":"Wang","year":"2025","journal-title":"Int J Pharm"},{"key":"10.1016\/j.apsb.2026.07.001_bib266","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.celrep.2013.10.042","article-title":"Impaired autophagy in the lipid-storage disorder Niemann-Pick type C1 disease","volume":"5","author":"Sarkar","year":"2013","journal-title":"Cell Rep"},{"key":"10.1016\/j.apsb.2026.07.001_bib267","doi-asserted-by":"crossref","first-page":"R33","DOI":"10.1016\/j.cub.2012.10.041","article-title":"The role of lipids in the control of autophagy","volume":"23","author":"Dall'Armi","year":"2013","journal-title":"Curr Biol"},{"key":"10.1016\/j.apsb.2026.07.001_bib268","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41419-022-04593-3","article-title":"The regulation, function, and role of lipophagy, a form of selective autophagy, in metabolic disorders","volume":"13","author":"Zhang","year":"2022","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.apsb.2026.07.001_bib269","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/s41420-024-02224-8","article-title":"Lipids associated with autophagy: mechanisms and therapeutic targets","volume":"10","author":"Jarocki","year":"2024","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.apsb.2026.07.001_bib270","doi-asserted-by":"crossref","first-page":"6397","DOI":"10.1038\/s41467-025-61759-1","article-title":"PIP4K2C inhibition reverses autophagic flux impairment induced by SARS-CoV-2","volume":"16","author":"Karim","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.07.001_bib271","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.216812","article-title":"Membrane remodeling in clathrin-mediated endocytosis","volume":"131","author":"Haucke","year":"2018","journal-title":"J Cell Sci"},{"key":"10.1016\/j.apsb.2026.07.001_bib272","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1085\/jgp.200709913","article-title":"Direct regulation of BK channels by phosphatidylinositol 4,5-bisphosphate as a novel signaling pathway","volume":"132","author":"Vaithianathan","year":"2008","journal-title":"J Gen Physiol"},{"key":"10.1016\/j.apsb.2026.07.001_bib273","article-title":"Phosphatidylinositol synthesis at the endoplasmic reticulum","volume":"1865","author":"Blunsom","year":"2020","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"10.1016\/j.apsb.2026.07.001_bib274","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/s41580-022-00490-x","article-title":"Phosphoinositides as membrane organizers","volume":"23","author":"Posor","year":"2022","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.apsb.2026.07.001_bib275","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.105757","article-title":"Phosphoinositide switches in cell physiology \u2014 from molecular mechanisms to disease","volume":"300","author":"Lolicato","year":"2024","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2026.07.001_bib276","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1152\/physrev.00028.2012","article-title":"Phosphoinositides: tiny lipids with giant impact on cell regulation","volume":"93","author":"Balla","year":"2013","journal-title":"Physiol Rev"},{"key":"10.1016\/j.apsb.2026.07.001_bib277","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1042\/BST20150214","article-title":"Regulation of PtdIns(3,4,5)P3\/Akt signalling by inositol polyphosphate 5-phosphatases","volume":"44","author":"Eramo","year":"2016","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.apsb.2026.07.001_bib278","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s10565-024-09866-5","article-title":"Function and regulation of Rab GTPases in cancers","volume":"40","author":"Xu","year":"2024","journal-title":"Cell Biol Toxicol"},{"key":"10.1016\/j.apsb.2026.07.001_bib279","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1038\/s41467-024-46678-x","article-title":"Rab GTPases and phosphoinositides fine-tune SNAREs dependent targeting specificity of intracellular vesicle traffic","volume":"15","author":"Koike","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.07.001_bib280","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.medj.2021.12.002","article-title":"Comparative effectiveness of mRNA-1273 and BNT162b2 against symptomatic SARS-CoV-2 infection","volume":"3","author":"Puranik","year":"2022","journal-title":"Med"},{"key":"10.1016\/j.apsb.2026.07.001_bib281","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111953","article-title":"Engineering of the current nucleoside-modified mRNA-LNP vaccines against SARS-CoV-2","volume":"142","author":"Granados-Riveron","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.apsb.2026.07.001_bib282","doi-asserted-by":"crossref","first-page":"4408","DOI":"10.1021\/mp400140u","article-title":"Stabilization of distearoylphosphatidylcholine lamellar phases in propylene glycol using cholesterol","volume":"10","author":"Harvey","year":"2013","journal-title":"Mol Pharm"},{"key":"10.1016\/j.apsb.2026.07.001_bib283","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s10555-020-09872-z","article-title":"The role of lipid species in membranes and cancer-related changes","volume":"39","author":"Skotland","year":"2020","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.apsb.2026.07.001_bib284","first-page":"81","article-title":"A review on phospholipids and their main applications in drug delivery systems","volume":"10","author":"Li","year":"2015","journal-title":"Asian J Pharm Sci"},{"key":"10.1016\/j.apsb.2026.07.001_bib285","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1002\/1873-3468.12919","article-title":"From yeast to humans\u2014roles of the Kennedy pathway for phosphatidylcholine synthesis","volume":"592","author":"McMaster","year":"2018","journal-title":"FEBS Lett"},{"key":"10.1016\/j.apsb.2026.07.001_bib286","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1023\/A:1015944828973","article-title":"Phospholipase D\/phosphatidic acid signal transduction: role and physiological significance in lung","volume":"234\u20135","author":"Cummings","year":"2002","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.apsb.2026.07.001_bib287","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1529\/biophysj.107.108787","article-title":"Phospholipase D activity is regulated by product segregation and the structure formation of phosphatidic acid within model membranes","volume":"93","author":"Wagner","year":"2007","journal-title":"Biophys J"},{"key":"10.1016\/j.apsb.2026.07.001_bib288","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1124\/pr.114.009217","article-title":"Phospholipase D signaling pathways and phosphatidic acid as therapeutic targets in cancer","volume":"66","author":"Bruntz","year":"2014","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.apsb.2026.07.001_bib289","series-title":"Williams textbook of endocrinology","first-page":"1660","article-title":"Chapter 37: disorders of lipid metabolism","author":"Semenkovich","year":"2016"},{"key":"10.1016\/j.apsb.2026.07.001_bib290","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0197-0186(94)90103-1","article-title":"Phosphatidic acid promotes phosphoinositide metabolism and DNA synthesis in cultured cortical astrocytes","volume":"24","author":"Pearce","year":"1994","journal-title":"Neurochem Int"},{"key":"10.1016\/j.apsb.2026.07.001_bib291","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jconrel.2022.06.051","article-title":"Lipid nanoparticles to silence androgen receptor variants for prostate cancer therapy","volume":"349","author":"Quick","year":"2022","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2026.07.001_bib292","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jpba.2015.11.020","article-title":"A versatile, quantitative analytical method for pharmaceutical relevant lipids in drug delivery systems","volume":"119","author":"Jeschek","year":"2016","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.apsb.2026.07.001_bib293","first-page":"47","article-title":"Chapter Three - linking chemical degradation and physical instability of lipid vesicles","volume":"vol. 41","author":"Rezaei","year":"2025"},{"key":"10.1016\/j.apsb.2026.07.001_bib294","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2019.06.037","article-title":"Osh proteins control nanoscale lipid organization necessary for PI(4,5)P2 synthesis","volume":"75","author":"Nishimura","year":"2019","journal-title":"Mol Cell"},{"key":"10.1016\/j.apsb.2026.07.001_bib295","doi-asserted-by":"crossref","DOI":"10.1091\/mbc.E23-03-0089","article-title":"Osh-dependent and -independent regulation of PI4P levels during polarized growth of Saccharomyces cerevisiae","volume":"34","author":"Heckle","year":"2023","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.apsb.2026.07.001_bib296","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev.cellbio.042308.113334","article-title":"The diverse functions of oxysterol-binding proteins","volume":"26","author":"Raychaudhuri","year":"2010","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10.1016\/j.apsb.2026.07.001_bib297","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1016\/j.freeradbiomed.2004.08.027","article-title":"Signaling kinases modulated by 4-hydroxynonenal","volume":"37","author":"Leonarduzzi","year":"2004","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.apsb.2026.07.001_bib298","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.abb.2008.06.011","article-title":"The chemistry of cell signaling by reactive oxygen and nitrogen species and 4-hydroxynonenal","volume":"477","author":"Forman","year":"2008","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.apsb.2026.07.001_bib299","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1124874","article-title":"Rate thresholds in cell signaling have functional and phenotypic consequences in non-linear time-dependent environments","volume":"11","author":"Thiemicke","year":"2023","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.apsb.2026.07.001_bib300","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41419-025-07616-x","article-title":"Phosphoinositide signaling at the cytoskeleton in the regulation of cell dynamics","volume":"16","author":"Hou","year":"2025","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.apsb.2026.07.001_bib301","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1128\/EC.00013-15","article-title":"Role of phosphatidylinositol phosphate signaling in the regulation of the filamentous-growth mitogen-activated protein kinase pathway","volume":"14","author":"Adhikari","year":"2015","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.apsb.2026.07.001_bib302","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40580-022-00298-7","article-title":"The cellular response to plasma membrane disruption for nanomaterial delivery","volume":"9","author":"Houthaeve","year":"2022","journal-title":"Nano Converg"},{"key":"10.1016\/j.apsb.2026.07.001_bib303","doi-asserted-by":"crossref","first-page":"11038","DOI":"10.1039\/D2NR05982G","article-title":"The lipidomic profile of the nanoparticle-biomolecule corona reflects the diversity of plasma lipids","volume":"15","author":"Papafilippou","year":"2023","journal-title":"Nanoscale"},{"key":"10.1016\/j.apsb.2026.07.001_bib304","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1007\/s00125-003-1223-4","article-title":"MAP kinases and mTOR mediate insulin-induced phosphorylation of insulin receptor substrate-1 on serine residues 307, 612 and 632","volume":"46","author":"Gual","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.apsb.2026.07.001_bib305","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.celrep.2016.08.086","article-title":"mTORC1 is a major regulatory node in the FGF21 signaling network in adipocytes","volume":"17","author":"Minard","year":"2016","journal-title":"Cell Rep"},{"key":"10.1016\/j.apsb.2026.07.001_bib306","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1226655","article-title":"Insulin signaling and its application","volume":"14","author":"Le","year":"2023","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.apsb.2026.07.001_bib307","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41541-023-00742-7","article-title":"Duration of SARS-CoV-2 mRNA vaccine persistence and factors associated with cardiac involvement in recently vaccinated patients","volume":"8","author":"Krauson","year":"2023","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.apsb.2026.07.001_bib308","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1292568","article-title":"Rapid transient and longer-lasting innate cytokine changes associated with adaptive immunity after repeated SARS-CoV-2 BNT162b2 mRNA vaccinations","volume":"14","author":"Rosati","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2026.07.001_bib309","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1038\/s12276-023-01086-x","article-title":"Immunogenicity of lipid nanoparticles and its impact on the efficacy of mRNA vaccines and therapeutics","volume":"55","author":"Lee","year":"2023","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.apsb.2026.07.001_bib310","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1128\/MCB.20.2.617-627.2000","article-title":"Activation of p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase by double-stranded RNA and encephalomyocarditis virus: involvement of RNase L, protein kinase R, and alternative pathways","volume":"20","author":"Iordanov","year":"2000","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.apsb.2026.07.001_bib311","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2022.146548","article-title":"MAP kinases are involved in RNA polymerase III regulation upon LPS treatment in macrophages","volume":"831","author":"Jurkiewicz","year":"2022","journal-title":"Gene"},{"key":"10.1016\/j.apsb.2026.07.001_bib312","article-title":"p38 MAPK regulates PKA\u03b1 and CUB-serine protease in Amphibalanus amphitrite cyprids","volume":"5","author":"Zhang","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2026.07.001_bib313","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41419-019-1882-9","article-title":"Protease Nexin I is a feedback regulator of EGF\/PKC\/MAPK\/EGR1 signaling in breast cancer cells metastasis and stemness","volume":"10","author":"Tang","year":"2019","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.apsb.2026.07.001_bib314","doi-asserted-by":"crossref","first-page":"4906","DOI":"10.3390\/ijms24054906","article-title":"Regulation of MAPK signaling pathways by the large HERC ubiquitin ligases","volume":"24","author":"Sala-Gaston","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2026.07.001_bib315","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41541-017-0032-6","article-title":"Unmodified mRNA in LNPs constitutes a competitive technology for prophylactic vaccines","volume":"2","author":"Lutz","year":"2017","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.apsb.2026.07.001_bib316","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s12964-025-02278-w","article-title":"RNA polymerase II subunit 5-mediating protein limits TLR4-induced innate immune activation in macrophages by inhibiting IKK\u03b2\/NF-\u03baB signaling during sepsis","volume":"23","author":"Pang","year":"2025","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.apsb.2026.07.001_bib317","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.immuni.2020.03.009","article-title":"Immune sensing of synthetic, bacterial, and protozoan RNA by toll-like receptor 8 requires coordinated processing by RNase T2 and RNase 2","volume":"52","author":"Ostendorf","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.apsb.2026.07.001_bib318","doi-asserted-by":"crossref","DOI":"10.1126\/science.abo3627","article-title":"Inborn errors of OAS-RNase L in SARS-CoV-2-related multisystem inflammatory syndrome in children","volume":"379","author":"Lee","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.apsb.2026.07.001_bib319","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1476-5381.2012.02205.x","article-title":"Cross-talk between toll-like receptor 4 (TLR4) and proteinase-activated receptor 2 (PAR2) is involved in vascular function","volume":"168","author":"Bucci","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.apsb.2026.07.001_bib320","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2003708","article-title":"Ubiquitin-specific protease 25 regulates TLR4-dependent innate immune responses through deubiquitination of the adaptor protein TRAF3","volume":"6","author":"Zhong","year":"2013","journal-title":"Sci Signal"},{"key":"10.1016\/j.apsb.2026.07.001_bib321","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.3390\/cells11091422","article-title":"Proteostasis perturbations and their roles in causing sterile inflammation and autoinflammatory diseases","volume":"11","author":"Papendorf","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.apsb.2026.07.001_bib322","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/imcb.12194","article-title":"Transfection reagent Lipofectamine triggers type I interferon signaling activation in macrophages","volume":"97","author":"Guo","year":"2019","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.apsb.2026.07.001_bib323","series-title":"Causality assessment of an adverse event following immunization (AEFI): user manual for the revised WHO classification","year":"2019"},{"key":"10.1016\/j.apsb.2026.07.001_bib324","doi-asserted-by":"crossref","first-page":"170","DOI":"10.12688\/f1000research.22600.1","article-title":"Causality assessment of adverse events following immunization: the problem of multifactorial pathology","volume":"9","author":"Bellavite","year":"2020","journal-title":"F1000Research"},{"key":"10.1016\/j.apsb.2026.07.001_bib325","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41540-025-00565-3","article-title":"Dynamical systems theory as an organizing principle for single-cell biology","volume":"11","author":"Islam","year":"2025","journal-title":"NPJ Syst Biol Appl"},{"key":"10.1016\/j.apsb.2026.07.001_bib326","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41540-025-00550-w","article-title":"Current state and open problems in universal differential equations for systems biology","volume":"11","author":"Philipps","year":"2025","journal-title":"NPJ Syst Biol Appl"},{"key":"10.1016\/j.apsb.2026.07.001_bib327","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/s44320-025-00164-8","article-title":"Cell cycle criticality as a mechanism for robust cell population control","volume":"22","author":"Simons","year":"2025","journal-title":"Mol Syst Biol"},{"key":"10.1016\/j.apsb.2026.07.001_bib328","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/s41576-025-00821-6","article-title":"Adapting systems biology to address the complexity of human disease in the single-cell era","volume":"26","author":"Fischer","year":"2025","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.apsb.2026.07.001_bib329","series-title":"Analytical procedures for quality of mRNA vaccines and therapeutics: draft guidelines","year":"2024"},{"key":"10.1016\/j.apsb.2026.07.001_bib330","series-title":"Guideline on the quality aspects of mRNA vaccines: draft. EMA\/CHMP\/BWP\/82416\/2025","year":"2025"},{"key":"10.1016\/j.apsb.2026.07.001_bib331","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jconrel.2021.05.021","article-title":"Impact of lipid nanoparticle size on mRNA vaccine immunogenicity","volume":"335","author":"Hassett","year":"2021","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2026.07.001_bib332","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s44222-026-00401-1","article-title":"Design principles of lipid nanoparticles for RNA delivery","volume":"4","author":"Arral","year":"2026","journal-title":"Nat Rev Bioeng 2026"},{"key":"10.1016\/j.apsb.2026.07.001_bib333","doi-asserted-by":"crossref","first-page":"12542","DOI":"10.1074\/jbc.M310175200","article-title":"mRNA is an endogenous ligand for toll-like receptor 3","volume":"279","author":"Karik\u00f3","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2026.07.001_bib334","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.immuni.2005.06.008","article-title":"Suppression of RNA recognition by toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA","volume":"23","author":"Karik\u00f3","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.apsb.2026.07.001_bib335","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/mt.2008.200","article-title":"Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability","volume":"16","author":"Karik\u00f3","year":"2008","journal-title":"Mol Ther"},{"key":"10.1016\/j.apsb.2026.07.001_bib336","doi-asserted-by":"crossref","first-page":"8119","DOI":"10.1038\/s41467-024-51301-0","article-title":"N1-Methylpseudouridine and pseudouridine modifications modulate mRNA decoding during translation","volume":"15","author":"Monroe","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.07.001_bib337","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.intimp.2007.04.006","article-title":"TLR-TLR cross talk in human PBMC resulting in synergistic and antagonistic regulation of type-1 and 2 interferons, IL-12 and TNF-alpha","volume":"7","author":"Ghosh","year":"2007","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.apsb.2026.07.001_bib338","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1161\/hc5001.100631","article-title":"Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL","volume":"104","author":"Xu","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.apsb.2026.07.001_bib339","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.atherosclerosis.2015.05.038","article-title":"The complement system and toll-like receptors as integrated players in the pathophysiology of atherosclerosis","volume":"241","author":"Hovland","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.apsb.2026.07.001_bib340","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1016\/j.celrep.2018.08.028","article-title":"TLR crosstalk activates LRP1 to recruit Rab8a and PI3K\u03b3 for suppression of inflammatory responses","volume":"24","author":"Luo","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.apsb.2026.07.001_bib341","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ceb.2016.01.010","article-title":"Functional crosstalk between membrane lipids and TLR biology","volume":"39","author":"K\u00f6berlin","year":"2016","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.apsb.2026.07.001_bib342","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1038\/s41467-023-37042-6","article-title":"The architecture of transmembrane and cytoplasmic juxtamembrane regions of toll-like receptors","volume":"14","author":"Kornilov","year":"2023","journal-title":"Nat Commun"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383526004235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383526004235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T23:21:33Z","timestamp":1789600893000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383526004235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":342,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2211383526004235"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2026.07.001","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipid nanoparticles as active biointerfaces: From membrane interaction to systemic dysregulation","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2026.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.","name":"copyright","label":"Copyright"}]}}